HAMLET Pharma AB

HAMLET Pharma is a Swedish pharmaceutical company based on the discovery that a human breast milk component kills tumor cells without harming healthy ones. Its lead candidate Alpha1H (alpha1 peptide-oleic acid complex) has completed a Phase I/II trial with positive results in bladder cancer. The company is a spin-out from Lund University, led by Prof. Catharina Svanborg.